Partnering to make
perimenopause care clearer,
prevention earlier,
and support easier
to act on.

For Clinicians & Clinics

Trusted care for women who arrive prepared

How we work together: Clinical care and pathway partner. Scita helps women move from uncertainty to a better-prepared conversation with a clinician. You provide the trusted assessment, treatment and referral pathways that turn that clarity into high-quality care.

Scita helps women organise symptoms, biomarkers, lifestyle patterns and risk signals before the appointment, so the clinical conversation can start from a more complete picture, not from isolated symptoms alone.

• Better-prepared patients with structured symptom, biomarker and lifestyle context
• More focused consultations and fewer repeated “start from scratch” assessments
• Clearer referral pathways across GP care, gynaecology, cardiology, endocrinology and other relevant specialties
• Better-matched patient flow from women actively seeking high-quality perimenopause care
• An opportunity to take part in Scita’s clinical validation pathway

For Research & Academic Partners

Building the evidence base together

How we work together: Evidence and validation partner. You help design, evaluate and strengthen the evidence behind Scita’s pathway. Research uses consented, privacy-preserving data. Individual data is never sold.

We are preparing a clinical validation pathway with Nordic research partners and welcome collaboration on study design, validation and evidence generation.

• Collaboration on study design and evidence generation
• Work designed with MDR readiness in mind
• A shared commitment to rigorous, GRADE-aligned standards

For Insurers, Payers & Benefit Platforms

From payer to prevention partner

How we work together: You help corporate clients and members move from fragmented, reactive care toward earlier perimenopause navigation and prevention. Scita brings symptoms, biomarkers, lifestyle and risk patterns together, so women can understand what is happening, clinicians can see more context, and benefit pathways can support care earlier.

For corporate clients, Scita offers a more clinically relevant way to support women during perimenopause: confidential, prevention-oriented and connected to care, rather than a generic wellbeing benefit.

Funding access does not mean access to individual health data or control over guidance.

• Members who understand their risk profile and can navigate care earlier
• Earlier identification of conditions that may drive future health risk and care complexity
• A benefit pathway designed around prevention, privacy and clinical context
• Support for corporate clients who want to retain talent while addressing a measurable productivity burden
• Built toward healthier long-term trajectories as evidence develops

For Public Health & Municipalities

Prevention as public infrastructure

How we work together: Public prevention and equitable access partner. You help explore how Scita can support earlier navigation, equitable access and population-level prevention, especially once clinical certification and evidence generation are in place.

Perimenopause is not only an individual health issue. It is a window where cardiometabolic, mental health, sleep and musculoskeletal risks can begin to shift, with consequences for prevention, workforce participation, health equity and avoidable system burden.

In the Nordics, good health care is something we fund together. Scita is built toward the clinical standard and data protection architecture that public adoption requires, with EU-sovereign infrastructure and GDPR-first design.

• Municipal prevention pilots that generate population-level engagement evidence
• A pathway toward publicly funded access once clinical certification is in place
• Support for earlier prevention before risks become more complex and costly
• Alignment with WHO/Europe public health innovation work